chrisvoncsefalvay/vaers-outcomes huggingface dataset:
One week later (overnight Apr 18/19) I woke during the night with fever (highest 101F) and lower right side abdominal pain. I called my primary care dr on Apr 19 at 10.15am. Due to prior history of intestinal surgery and resection July and Aug 2015, Dr advised me to go to Hospital ER for a CT scan. During some 7 hours in the ER, blood work, urinalysis, EKG and CT scan were done. The urinalysis showed possible UTI (though no other symptoms) and appendicitis was suspected from the CT scan. I also got a migraine during the hours in the ER. IV antibiotics and med for migraine were started and I was moved to a room. I saw surgeon and his team over the next two days. Another CT scan - with contrast drink - was done on Apr 20, and from this Dr advised the inflamed appendix was visible. Again due to my prior abdominal surgery and potential scar tissue Dr advised that removing the appendix in this state was at a bit higher risk. He suggested continuing IV antibiotics in the hospital for 48hrs and if the appendix responded well to finish oral antibiotics at home and then schedule appendectomy in approximately 6-8 weeks. This is now the plan. I am going for another CT scan with contrast drink next week in advance of potential appendectomy the week of June 14.
I got my period the day after the vaccine on May 22nd.  I wasn't due to get it for another week.  Then my period has come two more times starting on these dates:  July 25 & Sept. 6.  As you can see it's been extremely irregular.  Before the vaccine I was extremely regular, every 28 days.  I believe the vaccine really put a shock on my system.  I hope it's regulating itself back to normal.  I'll see if the next one comes when it should on Oct. 6th.
(per client) Client got weak in her legs and knees, chest slightly tight. decrease in memory. She was taken by w/c  to the ER department where she was evaluated. Vitals normal, no oxygen, rest. States she felt better within 5-10 minutes of getting to ER. Was discharged 90 minutes later and returned to work as a nurse. States that she does not think it was a reaction to medication as she was very anxious prior to getting injection and has history of anxiety attacks.
Chest pains, high heart rate, jerkiness, restless, muscle / body aches
Pt recvd vax & exp blindness in one eye, devel an abn gait, shuffling, & needed a cane to walk; pt was dx w/multiple sclerosis;
Patient received Td vaccine on 11/08/06 and complained of itchiness and redness on 11/13/06.  Follow up on 11/15/06: Patient's adverse reaction got worse-redness at injection site measured 16x22cm. Patient was given Keflex.  Follow up on 12/07/06: patient came back for a follow up appointment on 11/20/06, all of the symptoms resolved and patient recovered. Patient was not given any additional treatment after she was prescribed Keflex.
4/24/2021 Patient was observed post Covid-19 immunization for 15 minutes .  During the observation period, she experienced an adverse reaction with the following symptoms:  " slightly itchy neck". Assessment : Time of assessment Alert and oriented, Anxious and mild redness to neck from scratching. Vitals signs taken  VAERS form obtained and completed by RN. VS at 348pm- BP- 117/81, P- 95, O20 100%, Recheck at 1604pm- BP- 116/77, P- 82, O2- 100%, patient reports that she feels, "normal" , denies any further itching. Medications administered: Loratadine (Claritin) 10 mg  by mouth. Time: 348pm. Administered by RN. Famotidine (Pepcid) 20 mg by mouth. Time: 348pm. Administered by RN. Diphenhydramine (Benadryl) 12.5 ml (25 mg) by mouth. Time: 359pm. Administered by RN. Disposition: Reports no further symptoms of adverse reaction after observation for 30 minutes. Discharged home. Instructed to follow up with PCP  for evaluation for second dose. Instructed to call 911 for trouble breathing, rapid heart rate, dizziness, swelling of tongue or throat.
Systemic: mouth swelling and painful after 24 hours of having the shot-Mild
Pt presented in clinic,02/23/17 at 4:15pm with complaints of having diarrhea, feeling tired, vomiting and swelling & redness at injection sites, which had resolved by visit on 02/23.
extreme fatigue; high fever 39 degrees; nausea; fatigue; severe headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Nov-2021 and was forwarded to Moderna on 12-Nov-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (extreme fatigue), PYREXIA (high fever 39 degrees), NAUSEA (nausea), FATIGUE (fatigue) and HEADACHE (severe headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (extreme fatigue). an unknown date, the patient experienced PYREXIA (high fever 39 degrees), NAUSEA (nausea), FATIGUE (fatigue) and HEADACHE (severe headache). At the time of the report, FATIGUE (extreme fatigue) had not resolved and PYREXIA (high fever 39 degrees), NAUSEA (nausea), FATIGUE (fatigue) and HEADACHE (severe headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: fever 39 degrees (High) Fever 39 degrees.         No concomitant information was reported.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Nov-2021: Translation received on 17-NOV-2021 included: given  information was translated from native language to English.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022; No adverse event; Dose administered after 30-day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date or after manufacturer date of expiry) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 09-Jul-2022).    No concomitant product use was reported. On 04-Jun-2022 the vial was initially stored in the refrigerator. Vial did not undergone any temperature excursions. Patient received half dose on 09-Jul-2022. No treatment information was provided.
Facial nerve weakness, onset 1 day after immunization. Rx oral steroids, valacyclovir.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 10-NOV-2012 10:20, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
SWOLLEN AT INJECTION SITE; INJECTION SITE GREENISH PURPLE BRUISE COLOR; ABDOMINAL PAIN AND PRESSURE; INJECTION SITE SORE/TENDERNESS AT INJECTION SITE; FEVER; HEADACHE; CHILLS; This spontaneous report received from a patient concerned a 26 year old female. The patient's height, and weight were not reported. The patient's past medical history included covid-19 test. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced fever. On 10-APR-2021, the subject experienced headache. On 11-APR-2021, the subject experienced abdominal pain and pressure. On 11-APR-2021, the subject experienced injection site sore/tenderness at injection site. On 12-APR-2021, the subject experienced injection site greenish purple bruise color. On 12-APR-2021, the subject experienced swollen at injection site. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever, abdominal pain and pressure, injection site sore/tenderness at injection site, swollen at injection site, injection site greenish purple bruise color, and headache. This report was non-serious.
The injection was given in the top of my left shoulder with instant pain and burning. I had difficulty sleeping that evening and pain when using my left arm. I had an aqua fitness class to teach the next morning and had pain using that arm. This pain continued and worsened with use. It was difficult or impossible to sleep. I called the dr. office the 4th day to let them know about the intense pain. I went to immediate care on July 1st and was told that my shot probably went into the wrong place on my shoulder and was given muscle relaxants to see if that would help. It didn't ease the shoulder pain. I just learned not to use that arm and to hold it close to my body. I went back to my dr on July 5th to let them know what I was feeling and they set up an MRI. My MRI the following day showed bursitis and a split tear in the labrum of the left shoulder. An appoint was made to see an orthopedic surgeon.
Information has been received from a pharmacist concerning a 63 year-old female patient, who, on 20-MAY-2013, was vaccinated with a dose of ZOSTAVAX, subcutaneously (lot # J001004, expiry date 24-APR-2014, dose not provided). It was reported that, on 20-MAY-2013, the patient developed an immediate reaction. It was noted that, directly after receiving the vaccine, the patient complained of itching and minor swelling and sensitivity. The adverse symptoms worsened to include "significant swelling" from shoulder to elbow, intensified itching, redness and tenderness to the touch. The patient sought a medical attention by an emergency room visit (was not admitted). Unspecified topical antibiotic was prescribed as a treatment. It was also noted that this dose, along with another reported as an adverse experience, represented the last two doses remaining in this lot. All prior doses from the mentioned batch did not cause a reported reaction. The patient recovered from all the symptoms in June 2013. Relatedness for the reaction to the vaccine was not reported for ZOSTAVAX. Additional information has been requested. This is one of two reports from the same source. The other linked report is MARRS # 1306USA014277.
low grade fever, 99.6 degrees; Red spot on arm; Arm sore; Says she was fine after the booster vaccine; Says she was fine after the booster vaccine; This is a spontaneous report from a contactable pharmacist (patient). A 60-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EW0187, expiry date: not reported, Age at vaccination: 60-year-old) via an unspecified route of administration on 20Aug2021 as DOSE 3, SINGLE for COVID-19 immunization. The patient medical history included immunocompromised. Concomitant medications were not reported. Historical vaccine included bnt162b2 (Lot number: EL3249) on 14Jan2021 as DOSE 1 and bnt162b2 (Lot number: EN9581) on 04Feb2021 as DOSE 2, SINGLE for covid-19 immunization. On 21Aug2021, patient experienced low grade fever, red spot on arm, arm sore, off label use and extra dose administered. She stated that she got the second dose of the Pfizer Covid Vaccine because she is a MS patient and was not able to walk after the second dose of the vaccine. She stated that she is in the immunocompromised risk category so she was eligible for the booster vaccine. States she got it and just had a low grade fever and a red spot on her arm and that's it. She called her neurologist after not being able to walk after the second dose of the vaccine; but she has not called him since she got the booster vaccine. She had to call emergency medical services after the second dose of the vaccine because she got to the bathroom but then could not get back off of the toilet and couldn't walk. She got her booster vaccine last Thursday, then states it was 20Aug2021. Caller verifies that she got the vaccine on 20Aug2021. Says she was fine after the booster vaccine. The next day she had a low grade fever that got to maybe 99.6 degrees. Red spot on her arm was also sore. Says it was about the size of a quarter or a fifty cent piece. Says it has gotten smaller and her arm is only sore if she touches that area. She stated she just wanted to report that after having not been able to walk after the second vaccine; she had not a bad reaction after the booster. The outcome of events extra dose administered, off label use was unknown and for event low grade fever, 99.6 degrees, was recovered, for event, red spot on arm, arm sore was recovering.  Follow-Up (30Aug2021): Follow-up attempts are completed. No further information is expected.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 13-FEB-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time for the first time was 24 hours with the lowest recorded temperature of 33 Fahrenheit degree. The total cumulative excursion time of the second time was 48 hours with the lowest recorded temperature of 32 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
received booster on 1/14.  on 1/15 experienced the "usual" - fever, fatigue, aches, chills.    Adverse Reaction was Elevated Heart Rate.   normal resting HR is 58 - 65.    started around 2am while sleeping - HR started climbing 80bpm. at 7:30am 113bpm   Elevated HR all day at least 95.   During Nap lowest HR was 82 - 102.   took 2 weeks for heart rate to return to some sense of normalcy.  However, even as of May 1, HR is more elevated than normal during the day.  Resting HR  now 65 - 72.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender who on 03-JUL-2014 was vaccinated with an expired dose of M-M-R II (lot #H010134, expiration date 17-MAY-2014), subcutaneous. No adverse effects reported. The outcome was unknown. Additional information has been requested.
This case was reported by a consumer and described the occurrence of an injjection site reaction in a 4 year old female pt who received Infanrix. This case was received from the pt's parent; a physician or other health care professional has not verified this report. On 4/6/04, the pt received a dose of Infanrix in the right arm. At an unspecified time, post/vax, on 4/6/04, the pt experienced an injection site reaction characterized by swelling that extended to involve the entire shoulder area, warmth, redness and pruritus. The following day, on 4/7/04, the pt experienced injection site hives. The pt was seen at a physician's office and was treated with topical Benadryl. The events resolved on 4/16/04.
Became extremely congested and when I blew my nose became extremely syncopal, lasted about 2 hrs. Thought I was dying
Not given IM, went in SUBQ and infiltrated, completely missed deltoid, needs reeducation
It started with sniffles in the morning. I have to admit I wasn't paying a lot of attention because I was at a basketball game. I thought I had a head cold. On Saturday I was feeling achy. By the time I left the stadium, I was walking back to my car and noticed I had a fever and had a 3 hour drive home. On Sunday I tested positive. I was definitely running a fever, congestion, it was getting in my lungs. I called the urgent care people. She prescribed something but not, PAXLOVID. I filled the prescriptions she gave me on Sunday and taking ibuprofen and SUDAFED. By Tuesday I still hadn't gotten a hold of my doctor. I contacted program for COVID-19 positive patients and they gave me 70% PAXLOVID. I was feeling fatigued and tired. My appetite has been down. I did initially lose my taste and smell. Now I can taste and smell everything again.
1. Pain at the injection site. 2. Redness at the injection site. 3. Swelling at the injection site. 4. Tiredness 5. Headache 6. Muscle Pain 7. Chills 8. Fever (1.8 degrees over nominal). 9. Nausea  NOTE: Symptoms numbered 1 and 4 through 9 cleared up within 48 hours.  Symptoms 2 and 3 were still present during the evening of 04/04/2021.
No adverse event. Vaccine was given to a minor. J&J vaccine has not yet been approved for minors. Error was realized after event happened. Parent still signed consent, in addition to EAU given that stated must be 18yrs or older and signs posted. Health Dept. did call family after event, but family did not return the voicemail.
Tingling in finger tips of arm of the injection shot; numbing of the tip of tongue; headache; tenderness of injection sight; swollen lymph nodes; tenderness of left breast and left shoulder blade; tenderness of left breast and left shoulder blade; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 20 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Apr2021 13:00 (Batch/Lot number: unknown) at the age of 20 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PARAESTHESIA (non-serious) with onset 13Apr2021 13:30, outcome "recovered", described as "Tingling in finger tips of arm of the injection shot"; HYPOAESTHESIA ORAL (non-serious) with onset 13Apr2021 13:30, outcome "recovered", described as "numbing of the tip of tongue"; HEADACHE (non-serious) with onset 13Apr2021 13:30, outcome "recovered", described as "headache"; VACCINATION SITE PAIN (non-serious) with onset 13Apr2021 13:30, outcome "recovered", described as "tenderness of injection sight"; LYMPHADENOPATHY (non-serious) with onset 13Apr2021 13:30, outcome "recovered", described as "swollen lymph nodes"; BREAST TENDERNESS (non-serious), TENDERNESS (non-serious) all with onset 13Apr2021 13:30, outcome "recovered" and all described as "tenderness of left breast and left shoulder blade". Therapeutic measures were not taken as a result of paraesthesia, hypoaesthesia oral, headache, vaccination site pain, lymphadenopathy, breast tenderness, tenderness.  Additional information: Vaccine facility type was pharmacy or Drug store. Patient did not receive any vaccine in four weeks or Other medications in two weeks. Patient had no known allergies and did not had any other medical history. Patient had no COVID prior vaccination. COVID was not tested post vaccination.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received vaccines on 4/18/00. Pt has complained of left arm hurting "very bad", headache, chills and fever. Back hurts and muscle aches.  Follow - up call on 4/20/00. Pt doing very well, symptoms lasted 24 hours.
Information has been received from a physician concerning a 3 month old male who on 04-MAR-2007 was vaccinated with rotavirus vaccine live (human-bovine). In 2007 the patient experienced four loose stools a day. The physician stated that the stools did not contain blood and did not have a foul odor. The patient sought unspecified medical attention. The patient's four loose stools a day persisted. Additional information has been requested.
Moderna vaccine 0.5ml to (L) deltoid. Pt. states he felt squirt on his head. spoke to Patient. Pt will speak to his doctor & call us if pt want 2nd dose again. But Pt & vaccinator dont agree w/how much was given. Pt did have arm soreness at site.